Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
London’s investment trusts have been tapping a deep pool of equity capital earmarked for green-linked deals. On Friday, SDCL Energy Efficiency Income Trust (SEEIT), the UK-listed energy efficiency investor, closed a £160m raise, £60m more than its original target and on the same day Greencoat UK Wind, the investment trust focused on UK wind farms, launched a £197.6m follow-on. -
Renewable energy companies have rushed to the European equity capital markets in 2021 to issue about $2.3bn of paper, according to Dealogic data. The figure is by far the best ever start to a year for green equity issuance, and with investor demand for paper increasing, sources predict there will be much more supply to meet it.
-
Nordic Entertainment Group (NENT), a Swedish entertainment company that operates video streaming and television services, completed a Skr4.35bn ($523m) capital raise on Wednesday evening and attracted enough investor demand to price a larger deal than originally intended.
-
UK biotech firms are continuing to reap the benefits from US listings. On Tuesday Autolus Therapeutics, an early stage biopharma firm backed by Syncona Investments, became the latest UK Biotech firm to raise capital on the US Nasdaq in a $100m transaction. The deal shows the continued advantages for early stage European biotech firms in having a US listing.
-
Warehouse De Pauw (WDP), the Belgian operator of logistics sites and warehouses, raised €200m in an overnight equity block trade on Wednesday.
-
Cellnex, the Spanish telecoms infrastructure company, has returned to the equity capital markets with a huge €7bn rights issue to finance its acquisition of French competitor Hivory from Altice and KKR.
